Immuron (IMRN) Change in Inventory (2020 - 2023)

Immuron (IMRN) posted quarterly Change in Inventory of -$548101.0 for Q2 2023, down 180.77% on a QoQ basis from $678625.4 in Q2 2021.

Immuron (IMRN) Change in Inventory (2020 - 2023) Analysis & Trends

Immuron (IMRN) has reported Change in Inventory for 3 consecutive years, with -$548101.0 the latest figure, recorded in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 71.84 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immuron 270.20 Mn 258.54 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -548,100.97
Jun 30, 2023 -548,100.97
Jun 30, 2021 678,625.41
Jun 30, 2021 678,625.41
Jun 30, 2020 -80,251.84
Jun 30, 2020 -80,251.84